当前位置: X-MOL 学术Clin. Microbiol. Rev. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Point-of-Care HIV Viral Load Testing: an Essential Tool for a Sustainable Global HIV/AIDS Response.
Clinical Microbiology Reviews ( IF 19.0 ) Pub Date : 2019-05-15 , DOI: 10.1128/cmr.00097-18
Paul K Drain 1, 2, 3 , Jienchi Dorward 4, 5 , Andrew Bender 6 , Lorraine Lillis 7 , Francesco Marinucci 8 , Jilian Sacks 9 , Anna Bershteyn 10 , David S Boyle 7 , Jonathan D Posner 2, 6 , Nigel Garrett 4, 11
Affiliation  

The global public health community has set ambitious treatment targets to end the HIV/AIDS pandemic. With the notable absence of a cure, the goal of HIV treatment is to achieve sustained suppression of an HIV viral load, which allows for immunological recovery and reduces the risk of onward HIV transmission. Monitoring HIV viral load in people living with HIV is therefore central to maintaining effective individual antiretroviral therapy as well as monitoring progress toward achieving population targets for viral suppression. The capacity for laboratory-based HIV viral load testing has increased rapidly in low- and middle-income countries, but implementation of universal viral load monitoring is still hindered by several barriers and delays. New devices for point-of-care HIV viral load testing may be used near patients to improve HIV management by reducing the turnaround time for clinical test results. The implementation of near-patient testing using these new and emerging technologies may be an essential tool for ensuring a sustainable response that will ultimately enable an end to the HIV/AIDS pandemic. In this report, we review the current and emerging technology, the evidence for decentralized viral load monitoring by non-laboratory health care workers, and the additional considerations for expanding point-of-care HIV viral load testing.

中文翻译:

现场护理艾滋病毒病毒载量测试:全球艾滋病毒/艾滋病可持续应对的重要工具。

全球公共卫生界已经设定了雄心勃勃的治疗目标,以结束艾滋病毒/艾滋病的流行。在没有明显治愈的情况下,HIV治疗的目标是实现对HIV病毒载量的持续抑制,从而实现免疫学恢复并降低HIV继续传播的风险。因此,监测HIV感染者的HIV病毒载量对于维持有效的个体抗逆转录病毒疗法以及监测实现人群对病毒抑制的目标的进展至关重要。在低收入和中等收入国家,基于实验室的HIV病毒载量检测能力迅速提高,但由于若干障碍和延误,仍无法实施通用病毒载量监测。可以在患者附近使用用于护理点HIV病毒载量测试的新设备,以通过减少临床测试结果的周转时间来改善HIV管理。使用这些新兴技术进行近距离患者测试可能是确保可持续应对措施必不可少的工具,这将最终终结艾滋病毒/艾滋病的流行。在本报告中,我们回顾了当前和新兴技术,非实验室医护人员进行分散式病毒载量监测的证据,以及扩展医疗点HIV病毒载量检测的其他考虑因素。使用这些新兴技术进行近距离患者测试可能是确保可持续应对措施必不可少的工具,这将最终终结艾滋病毒/艾滋病的流行。在本报告中,我们回顾了当前和新兴技术,非实验室医护人员进行分散式病毒载量监测的证据,以及扩展医疗点HIV病毒载量检测的其他考虑因素。使用这些新兴技术进行近距离患者测试可能是确保可持续应对措施必不可少的工具,这将最终终结艾滋病毒/艾滋病的流行。在本报告中,我们回顾了当前和新兴技术,非实验室医护人员进行分散式病毒载量监测的证据,以及扩展医疗点HIV病毒载量检测的其他考虑因素。
更新日期:2019-11-01
down
wechat
bug